Abstract

Background: Simple sequence repeats (SSRs) are 1 - 6 bp repeat motif sequences present across both prokaryotic and eukaryotic genomes with various clinical implications besides being tools for conservation and evolutionary studies. Objectives: Analysis of 33 Coronavirus genomes, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for incidence, distribution, and complexity of SSRs patterns to understand their role in host divergence and evolution. Methods: Full-length genome sequences were extracted from National Center for Biotechnology Information (NCBI). Extraction of microsatellites was done using imperfect microsatellite extractor (IMEx) in “Advanced Mode”. Sequences were aligned with MAFFT v6.861b and the maximum likelihood tree was inferred using RAxML v8.1.20 of the GTR + GAMMA+I model with default specifications. Results: A total of 3,442 SSRs and 136 complex sequence repeats (cSSRs) were extracted from the studied 33 genomes. SSR incidence ranged from 82 (CV09) to 144 (CV60). cSSR incidence ranged from 1 (CV42, CV43, CV53) to 11 (CV32). CV61 (SARS-CoV-2) had 107 SSRs and 6 SSRs. Di-nucleotide motifs were the most prevalent followed by tri- and mono-nucleotide motifs. TG/GT was the most represented di-nucleotide motif, followed by CA/AC. In tri-nucleotide SSRs, ACA/TGT was the most represented motif followed by CAA/GTT, whereas in mono-nucleotide SSRs, T was the most observed nucleotide, followed by A. About 94% of SSRs were localized to the coding region. Twenty species, including CV61 (SARS-CoV-2), exhibit mono-nucleotide repeats exclusively in the A/T region, which were clustered in phylogenetic analysis. The sequence similarity of the genomes was assessed through heat map analysis and revealed similar sequences are expectedly placed in proximity on the phylogenetic tree. Conclusions: Mono-nucleotide exclusivity to A/T region and SSR genome signature can be a possible basis for predicting the evolution of viruses in terms of host range.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.